PHILADELPHIA — Cancer Discovery, a journal of the American Association for Cancer Research (AACR), reported an Impact Factor of 15.929 in 2014, which is a 57 percent increase over the 10.143 Impact Factor from 2013.
The journal ranked sixth out of 202 oncology journals, according to the latest Journal Citation Report from Thomson Reuters, the industry standard for journal impact measurement.
Cancer Discovery is co-led by editors-in-chief Lewis C. Cantley, PhD, director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College in New York and José Baselga, MD, PhD, physician-in-chief at Memorial Sloan Kettering Cancer Center in New York.
“The AACR is thrilled that the Cancer Discovery Impact Factor has increased so significantly this year,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “This shows that we are continuing to meet our goal of providing a publication outlet that captures the most compelling work across the breadth of the cancer research field. It is also a testament to the hard work and commitment of Drs. Cantley and Baselga, the co-editors-in-chief of the journal, and our expert scientific editors.”
Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in basic, translational, and clinical research, as well as cancer science news, review articles, perspectives, commentaries, and summaries of other important peer-reviewed journal articles.
Cancer Discovery is one of eight journals published by the AACR. The other journals are Cancer Epidemiology, Biomarkers & Prevention; Cancer Immunology Research; Cancer Prevention Research; Cancer Research; Clinical Cancer Research; Molecular Cancer Research; and Molecular Cancer Therapeutics.
Read more information on Cancer Discovery.